Repligen licenses uridine patent rights for treatment of bipolar … - News-Medical.Net
Repligen Corporation has announced that it has exclusively licensed worldwide rights for the use of uridine in the treatment of patients with bipolar disorder from McLean Hospital. The use of uridine in the treatment of patients with bipolar disorder …